Histiocytic Disorder Follow-up Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Histiocytic Disorder Follow-up Study — Stella

Home/Histiocytosis/

View on ClinicalTrials.gov

Recruiting

Back to Histiocytosis trials

Trial locations(1 site)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Key details

Sponsor

University of Alabama at Birmingham

Enrollment target

~6,000 participants

Started

September 2022

Primary completion

July 2027

Age range

0 Years – 89 Years

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.